Paper Details
- Home
- Paper Details
Investigations of calsequestrin as a target for anthracyclines: comparison of functional effects of daunorubicin, daunorubicinol, and trifluoperazine.
Author: BroylesT Stephen, CharlierHenry A, CusackBarry J, LarsonCorianton L, MercerWendy K, MuhlesteinDawn J, OlsonDavid R, OlsonRichard D, ShadleSusan E, ThornockCarissa M
Original Abstract of the Article :
Anthracycline therapy is associated with a life-threatening but poorly understood cardiotoxicity. Effects of treatment are consistent with drug-induced disruption of cardiac sarcoplasmic reticulum (SR) calcium homeostasis, including inhibition of calcium release by anthracyclines. This effect, which...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1124/mol.104.005728
データ提供:米国国立医学図書館(NLM)
Calsequestrin as a Target for Anthracyclines: Investigating Cardiotoxicity
This research delves into the [mechanisms of anthracycline cardiotoxicity], exploring the potential role of [calsequestrin (CSQ)] in [cardiac toxicity] associated with [anthracycline therapy]. The study utilizes [protein fluorescence quenching studies] and [muscle preparations] to investigate the [interactions of anthracyclines with CSQ]. The findings suggest that [anthracyclines can impair SR calcium release and cardiac function through a mechanism involving disruption of CSQ function], highlighting the [importance of understanding these interactions] for [preventing and managing cardiotoxicity].The Heart of the Matter: Understanding Anthracycline Cardiotoxicity
The study provides valuable insights into the [molecular mechanisms underlying anthracycline cardiotoxicity], emphasizing the [crucial role of CSQ] in [regulating calcium homeostasis] and [cardiac function]. The findings underscore the [importance of ongoing research] to develop [strategies for mitigating cardiotoxicity] and [improving patient outcomes] during anthracycline therapy.Navigating the Desert of Cardiotoxicity: A Focus on Heart Health
Anthracycline therapy is a powerful tool in cancer treatment, but it can have serious side effects. This study sheds light on the [molecular mechanisms of cardiotoxicity], helping healthcare professionals [understand the risks] and [develop strategies] to [protect patients' heart health] during therapy.Dr. Camel's Conclusion
Just as a camel traverses a desert, relying on its resilient heart to withstand the harsh conditions, individuals undergoing anthracycline therapy need careful monitoring and tailored approaches to protect their heart health. This study delves into the intricate world of cardiotoxicity, providing valuable insights for understanding and managing this challenging side effect of cancer treatment.Date :
- Date Completed 2005-06-15
- Date Revised 2015-11-19
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.